Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01755000 · ClinicalTrials.gov registry record · NA

Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings

A NA study, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
69
Enrollment target

NCT01755000: Completed NA study, sponsored by Washington University School of Medicine.

NCT01755000 is a NA study that has completed, run by Washington University School of Medicine. The registered enrollment target is 69 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01755000, a NA study, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
69 participants
Enrollment target

Study Summary

The purpose of this study is to test how practical it is to use the Ultrasonic Cardiac Output Monitor (USCOM), an FDA-approved device, on oncology patients (specifically those with blood cancers). Additionally, the researchers will learn if the USCOM gives additional information about patients' conditions when their blood pressures drop and they are treated with intravenous fluids.

Primary Outcome

Pairs of USCOM measurements from multiple raters for SV and Vpk, both of which are interval-level measures. Inter-rater reliability will be assessed using the Intraclass Correlation Coefficient (ICC); our design fits into case 1 using the Shrout and Fleiss (1979) classification system.

Interventions

  • PROCEDURE USCOM scan
  • PROCEDURE Fluid Bolus

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2012-12
Est. Completion 2013-04
Phase NA

What the finished NCT01755000 record still lists

NCT01755000 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which USCOM scan is the first listed.

NCT01755000 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01755000 about?

NCT01755000 is a clinical study titled "Study of Hypotensive Hematopoietic Malignancy Patients' USCOM Readings". The purpose of this study is to test how practical it is to use the Ultrasonic Cardiac Output Monitor (USCOM), an FDA-approved device, on oncology patients (specifically those with blood cancers). Additionally, the researchers will learn if the USCOM gives additional information about patients' cond...

What is the current status of trial NCT01755000?

This trial is currently completed. It is a NA study. The enrollment target is 69 participants. The study started on 2012-12. Estimated completion is 2013-04.

What interventions are being tested in trial NCT01755000?

The interventions under investigation include: USCOM scan (PROCEDURE), Fluid Bolus (PROCEDURE).

Who is sponsoring clinical trial NCT01755000?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01755000's enrollment target sits among peer trials

69 1133rd of 2000 higher than 868 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01755000, the US trial registry maintained by the National Library of Medicine. NCT01755000 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.